Virtual monitoring in CF – the importance of continuous monitoring in a multi-organ chronic condition
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index; 23 of the 56 sources its claims cite were checked for support.
Abstract
Cystic Fibrosis (CF) is a chronic life-limiting condition that affects multiple organs within the body. Patients must adhere to strict medication regimens, physiotherapy, diet, and attend regular clinic appointments to manage their condition effectively. This necessary but burdensome requirement has prompted investigations into how different digital health technologies can enhance current care by providing the opportunity to virtually monitor patients. This review explores how virtual monitoring has been harnessed for assessment or performance of physiotherapy/exercise, diet/nutrition, symptom monitoring, medication adherence, and wellbeing/mental-health in people with CF. This review will also briefly discuss the potential future of CF virtual monitoring and some common barriers to its current adoption and implementation within CF. Due to the multifaceted nature of CF, it is anticipated that this review will be relevant to not only the CF community, but also those investigating and developing digital health solutions for the management of other chronic diseases. 2023 Vagg, Deasy, Chapman, Ranganathan, Plant and Shanthikumar.
Overview
CoChat Summary
TL;DR
This review synthesizes virtual monitoring approaches in cystic fibrosis (CF) across physiotherapy/exercise, diet/nutrition, symptom monitoring, medication adherence, and mental health. It concludes these approaches are generally acceptable, feasible, and usable, but highlights major barriers including small studies, lack of standardization, the digital divide, and poor sustained use.
Key findings
- Virtual monitoring for CF physiotherapy/exercise was acceptable to children/adolescents and clinicians in the UK, and in an Irish study with a Fitbit Charge 2, weekly encouraging text messages were associated with a significant increase in step count, but not in clinical parameters.
- Symptom monitoring is one of the most studied areas: an early home-symptom study (1984–1992) reported no negative impact on patients and slower lung function decline versus controls; a 2017 multicentre randomised trial of 267 adolescent/adult PwCF detected more pulmonary exacerbations in the intervention arm, but no difference in lung function decline.
- The MyCyFAPP nutrition system showed benefit: in children, pre/post comparison over six months found better macronutrient distribution (more protein and fat, less carbohydrates) and less intake of ultra-processed food.
- Digital monitoring for adherence and mental health appears promising: CFHealthHub was rolled out to 19 CF centres, while the ACT telehealth pilot found virtual sessions were as effective as in-person sessions and improved psychosocial function and lung function post-treatment; online CF-CBT was reported as feasible and acceptable.
Methods
- This is a narrative review of virtual monitoring in CF, framed as remote collection of medical and health data used to guide patient care in a pre-emptive or proactive manner.
- The authors searched PubMed, Web of Science, and Scopus, with no year restriction, using CF-related terms combined with virtual/remote/digital health terms.
- The paper synthesizes prior studies spanning surveys, pilot studies, multicentre studies, and randomized trials; it does not report a new primary sample.
Limitations
- Stated by the paper: many studies were small pilot studies focused on usability and feasibility; there is a need for standardized evaluation and reporting methods; two studies noted inability to sustain virtual monitoring over time; and no studies discussed costs.
- Stated by the paper: current CF mental-health digital interventions are sparse, and available mHealth evidence was described as low quality due to small sample sizes, pilot-only evidence, and homogeneity in data.
- Evident from the text: the review is descriptive and does not provide a formal meta-analysis or pooled effect estimates, so conclusions depend on heterogeneous underlying studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
22 Valid · 1 Not valid · 26 Not checked · 15 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, specific digital health interventions for CF mental health are lacking (24, 25).”
§ Virtual monitoring in CF – the importance of continuous monitoring in a multi-organ chronic condition > Virtual monitoring in CF care > Virtual monitoring for CF wellbeing and mental-health care
What the sources say
- Partly supportedcites [24] O’Hayer, 2021, ACT with CF: a telehealth and in-person feasibility study to address anxiety and depressive symptoms among people with cystic fibrosis, J Cyst Fibros sourceExperimental — accuracy not yet measured
The Background states that CF-specific targeted psychotherapeutic interventions were lacking, supporting the general mental-health treatment gap. It does not specifically establish a lack of digital interventions; the Introduction describes a CF-specific protocol designed for telehealth delivery, and the Results report its use. (LLM, conf=0.86)
- Not matchedcites [25] Verkleij
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The pre and post data comparison found that the app led to better macronutrient distribution (more protein and fat, less carbohydrates) and less intake of ultra-processed food.”
§ Virtual monitoring in CF – the importance of continuous monitoring in a multi-organ chronic condition > Virtual monitoring in CF care > Virtual monitoring for CF diet/nutrition A CF specific diet is a key aspect of CF care, and one of the strongest exemplars of virtual monitoring to support CF nutrition self-management is the MyCyFAPP, an international collaboration between 12 European organisations (9, 10). This system encompasses a patient focused mobile health (mHealth) application to disseminate educational and nutrition information for parents of children with CF, educational games for children with CF, diet trackers, and Pancreatic Enzyme Replacement Treatment (PERT) calculators. This mHealth system also has an integrated web-tool to display variable analytics to medical professionals, while simultaneously allowing CF dietitians to send recommendations/corrections to the patient. The latest iteration of this research includes a predictive model for optimal PERT adjustment to provide patients with their own specific number of enzymes per meal/food product. To date, use of the MyCyFAPP has shown benefit. Children had their diet analysed before using the app, and six months after using the app. The pre and post data comparison found that the app led to better macronutrient distribution (more protein and fat, less carbohydrates) and less intake of ultra-processed food. Another common example of virtual monitoring in CF dietetics is the use of Continuous Glucose Monitoring (CGM) devices in those with CF related diabetes. These devices are worn by the patient and continuously read glucose levels and display these data in a report found on an accompanying app. A recent systematic review found that CGM may improve glycaemic control in CF related diabetes compared to standard finger prick glucose monitoring (11).
What the sources say
- Partly supportedcites [9] Calvo-Lerma, 2021, Change in nutrient and dietary intake in European children with cystic fibrosis after a 6-month intervention with a self-management mHealth tool, Nutrients sourceExperimental — accuracy not yet measured
The Results (§3.2) report that after six months of MyCyFAPP use, protein and fat made up larger shares of energy intake and carbohydrates a smaller share, bringing the distribution closer to guidelines. The Discussion suggests the app could have motivated these changes, but the paper does not establish that the app caused them; its Abstract says the findings need validation against a control group. (LLM, conf=0.85)
- Not matchedcites [10]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In 2018 Shelley et al. surveyed children/adolescents with CF and their clinicians in the UK and found that physical activity monitoring devices were acceptable to both patients and medical professionals and can contribute to better understanding of the barriers preventing exercise (4).”
§ Virtual monitoring in CF – the importance of continuous monitoring in a multi-organ chronic condition > Virtual monitoring in CF care > Virtual monitoring for CF physiotherapy & exercise
What the sources say
- Partly supportedcites [4] Shelley, 2018, A formative study exploring perceptions of physical activity and physical activity monitoring among children and young people with cystic fibrosis and health care professionals, BMC Pediatr sourceExperimental — accuracy not yet measured
The Discussion (Phase 2 and phase 3; page not provided) reports that monitoring devices were acceptable to both patients and clinicians. The Background says clinicians need to understand barriers to physical activity, but the paper does not establish that the devices themselves identify barriers preventing exercise; it describes their potential to provide activity data and inform interventions. (LLM, conf=0.84)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In 2018 Shelley et al. surveyed children/adolescents with CF and their clinicians in the UK and found that physical activity monitoring devices were acceptable to both patients and medical professionals and can contribute to better understanding of the barriers preventing exercise (4).”
§ Virtual monitoring in CF – the importance of continuous monitoring in a multi-organ chronic condition > Virtual monitoring in CF care > Virtual monitoring for CF physiotherapy & exercise
What the sources say
- Supportedcites [4] Shelley, 2018, A formative study exploring perceptions of physical activity and physical activity monitoring among children and young people with cystic fibrosis and health care professionals, BMC Pediatr source
The Discussion (Phase 2 and phase 3) explicitly says qualitative data supported the acceptability of physical activity monitoring devices among both patients and clinicians. The Results (Phase 3 and health care professional interviews) likewise report that participants enjoyed testing the devices and that acceptability among clinicians was strong. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The initial pilot study found that the virtual sessions were as effective as in-person sessions, and improved both psychosocial functions and lung”
§ Virtual monitoring in CF – the importance of continuous monitoring in a multi-organ chronic condition > Virtual monitoring in CF care > Virtual monitoring for CF wellbeing and mental-health care Like most chronic conditions, PwCF and their families are at greater risk of mental health issues due to multiple factors (22). Additionally, there are significant associations between positive mental health and self-reported physical health and quality of life (23). As such, much research investigating virtual monitoring for overall CF self-management often report the effects on overall depression and anxiety levels in patients. However, specific digital health interventions for CF mental health are lacking (24, 25). Amerio et al. in 2020 further suggested that with the recent advances in CF therapies, CF care is at a pivotal time to move from secondary prevention of mental health issues, and instead move to predicting patients' susceptibility and pro-actively treating (26). The concept of integrating predictive models could lend itself well to virtual monitoring techniques, however to date such a digital health system is yet to be created for CF care. Instead, telehealth technologies are currently being used to deliver remote counselling without monitoring or recording of additional data. One example of this is the Acceptance and Commitment Therapy (ACT) telehealth study launched in 2021 which delivered six virtual or in person sessions to adult CF patients. The initial pilot study found that the virtual sessions were as effective as in-person sessions, and improved both psychosocial functions and lung function post-treatment (24). Similarly in 2021 and 2022, online Cognitive Behavioural Therapy for CF (CF-CBT) was delivered to adult CF patients. Pilot data from these studies also demonstrate that the online CF-CBT program was both feasible and acceptable (27). In addition to the sparsity of available research for this CF focus, a systematic review in 2021 investigating mHealth apps for CF emotional and physical health concluded that current available research was of low quality due to small sample sizes, limited to pilot studies, and with homogeneity in data (28).
What the sources say
- Supportedcites [24] O’Hayer, 2021, ACT with CF: a telehealth and in-person feasibility study to address anxiety and depressive symptoms among people with cystic fibrosis, J Cyst Fibros source
The Results report improvements in psychosocial functioning and a significant reduction in psychological distress from before to after treatment. They also report that telehealth-delivered ACT was as effective as in-person ACT. The reduction in distress was not sustained at three months, but the claim is limited to post-treatment outcomes. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
34 more claims · 9 with their cited sources checked
Create a free account to see all 64 claims and every source verdict.
- Probably not a substantial claim. 16
- It may state two separate claims as one. 11
Citations
Cites
European cystic fibrosis society standards of care: best practice guidelines
Smyth, A. R., Bell, S. C., Bojcin, S., Bryon, M., Duff, A., Flume, P., Kashirskaya, N., Munck, A., Ratjen, F., Schwarzenberg, S. J., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.03.010 · Cited by 582
Quittner, A. L., Goldbeck, L., Abbott, J., Duff, A., Lambrecht, P., Solé, A., Tibosch, M. M., Bergsten Brucefors, A., Yüksel, H., Catastini, P., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205983 · Cited by 524 · cited 1×
“Like most chronic conditions, PwCF and their families are at greater risk of mental health issues due to multiple factors (22).”
BackgroundHigh treatment burden in adults with cystic fibrosis: challenges to disease self-management
Sawicki, G. S., Sellers, D. E., & Robinson, W. M. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.09.007 · Cited by 498
Lechtzin, N., Mayer-Hamblett, N., West, N. E., Allgood, S., Wilhelm, E., Khan, U., Aitken, M. L., Ramsey, B. W., Boyle, M. P., Mogayzel, P. J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201610-2172oc · Cited by 127
Wearable Sweat Sensors: Background and Current Trends
Kaya, T., Liu, G., Ho, J. C.-T., Yelamarthi, K., Miller, K. C., Edwards, J. E., & Stannard, A. B. (2018) · Electroanalysis · doi:10.1002/elan.201800677 · Cited by 104
Home monitoring in interstitial lung diseases
Wijsenbeek, M. S., Moor, C. C., Johannson, K. A., Jackson, P. D., Khor, Y. H., Kondoh, Y., Rajan, S. K., Tabaj, G. C., Varela, B. E., van der Wal, P., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00228-4 · Cited by 98 · cited 2×
“These reviews also outline emerging virtual monitoring focuses not yet explored in CF such as remote/portable diagnostic imaging (39), and home sample testing (blood) (42).”
BackgroundPrognostication and risk factors for cystic fibrosis via automated machine learning
Alaa, A. M., & van der Schaar, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-29523-2 · Cited by 80 · cited 1×
“An unvalidated proof of concept of this has already been developed using CF registry data in the UK to assess optimal time for lung transplant referral (32).”
MethodCalthorpe, R. J., Smith, S., Gathercole, K., & Smyth, A. R. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-213233 · Cited by 61
Sputum and salivary protein biomarkers and point-of-care biosensors for the management of COPD
Dong, T., Santos, S. M. B., Yang, Z., Yang, S., & Kirkhus, N. E. (2019) · The Analyst · doi:10.1039/c9an01704f · Cited by 52
Arden, M. A., Hutchings, M., Whelan, P., Drabble, S. J., Beever, D., Bradley, J. M., Hind, D., Ainsworth, J., Maguire, C., Cantrill, H., et al. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00739-2 · Cited by 44
Cited by
Monitoring respiratory function with telemedicine devices in asthmatic children
Kapus, K., Rárosi, F., Novàk, Z., Peták, F., & Tolnai, J. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1604909 · Cited by 2
Metadata
- Authors
- Vagg, T., Deasy, K. F., Chapman, W. W., Ranganathan, S. C., Plant, B. J., & Shanthikumar, S.
- Affiliations
- University College Cork (IE)
- The University of Melbourne (AU)
- Royal Children's Hospital (AU)
- Corresponding author
- Vagg, Tamara
- ORCID
- Venue
- Frontiers in Digital Health
- Publisher
- Frontiers Media SA
- Published
- 2023-05-04
- Volume
- 5
- Pages
- 1196442-1196442
- ISSN
- 2673-253X (ISSN-L)
- PMC
- PMC10192704
- OpenAlex
- W4377564502
- Cited by
- 1
- References
- 38
- Citations by year
- 2025: 1
- FWCI
- 0.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Digital Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion, cc-by)
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Keywords
- cystic fibrosis, virtual monitoring, digital health technologies, remote patient monitoring, physiotherapy, exercise monitoring, diet and nutrition, symptom monitoring, medication adherence, mental health, well-being, chronic disease management, barriers to adoption
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Virtual monitoring in CF – the importance of continuous monitoring in a multi-organ chronic condition. https://app.cochat.ai/papers/10.3389/fdgth.2023.1196442
- The paper
- Vagg, T., Deasy, K. F., Chapman, W. W., Ranganathan, S. C., Plant, B. J., & Shanthikumar, S. (2023). Virtual monitoring in CF – the importance of continuous monitoring in a multi-organ chronic condition. Frontiers in Digital Health. https://doi.org/10.3389/fdgth.2023.1196442
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
